Portelius E - Search Results

1

Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.

Pannee J, Gobom J, Shaw LM, Korecka M, Chambers EE, Lame M, Jenkins R, Mylott W, Carrillo MC, Zegers I, Zetterberg H, Blennow K, Portelius E. Pannee J, et al. Among authors: portelius e. Alzheimers Dement. 2016 Jan;12(1):55-9. doi: 10.1016/j.jalz.2015.06.1890. Epub 2015 Jul 21. Alzheimers Dement. 2016. PMID: 26206625

2

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.

Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K. Portelius E, et al. J Proteome Res. 2006 Apr;5(4):1010-6. doi: 10.1021/pr050475v. J Proteome Res. 2006. PMID: 16602710

3

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.

Portelius E, Zetterberg H, Andreasson U, Brinkmalm G, Andreasen N, Wallin A, Westman-Brinkmalm A, Blennow K. Portelius E, et al. Neurosci Lett. 2006 Dec 6;409(3):215-9. doi: 10.1016/j.neulet.2006.09.044. Epub 2006 Oct 17. Neurosci Lett. 2006. PMID: 17049739

4

Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment.

Thorsell A, Portelius E, Blennow K, Westman-Brinkmalm A. Thorsell A, et al. Among authors: portelius e. Rapid Commun Mass Spectrom. 2007;21(5):771-8. doi: 10.1002/rcm.2898. Rapid Commun Mass Spectrom. 2007. PMID: 17279600

5

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry.

Portelius E, Tran AJ, Andreasson U, Persson R, Brinkmalm G, Zetterberg H, Blennow K, Westman-Brinkmalm A. Portelius E, et al. J Proteome Res. 2007 Nov;6(11):4433-9. doi: 10.1021/pr0703627. Epub 2007 Oct 10. J Proteome Res. 2007. PMID: 17927230

6

Characterization of tau in cerebrospinal fluid using mass spectrometry.

Portelius E, Hansson SF, Tran AJ, Zetterberg H, Grognet P, Vanmechelen E, Höglund K, Brinkmalm G, Westman-Brinkmalm A, Nordhoff E, Blennow K, Gobom J. Portelius E, et al. J Proteome Res. 2008 May;7(5):2114-20. doi: 10.1021/pr7008669. Epub 2008 Mar 20. J Proteome Res. 2008. PMID: 18351740

7

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

Portelius E, Zetterberg H, Gobom J, Andreasson U, Blennow K. Portelius E, et al. Expert Rev Proteomics. 2008 Apr;5(2):225-37. doi: 10.1586/14789450.5.2.225. Expert Rev Proteomics. 2008. PMID: 18466053 Review.

8

Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.

Wasling P, Daborg J, Riebe I, Andersson M, Portelius E, Blennow K, Hanse E, Zetterberg H. Wasling P, et al. Among authors: portelius e. J Alzheimers Dis. 2009;16(1):1-14. doi: 10.3233/JAD-2009-0918. J Alzheimers Dis. 2009. PMID: 19158416 Review.

9

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.

Portelius E, Brinkmalm G, Tran AJ, Zetterberg H, Westman-Brinkmalm A, Blennow K. Portelius E, et al. Neurodegener Dis. 2009;6(3):87-94. doi: 10.1159/000203774. Epub 2009 Feb 20. Neurodegener Dis. 2009. PMID: 19229112

10

Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases.

Westman-Brinkmalm A, Ruetschi U, Portelius E, Andreasson U, Brinkmalm G, Karlsson G, Hansson S, Zetterberg H, Blennow K. Westman-Brinkmalm A, et al. Among authors: portelius e. Front Biosci (Landmark Ed). 2009 Jan 1;14(5):1793-806. doi: 10.2741/3341. Front Biosci (Landmark Ed). 2009. PMID: 19273163 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters